CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02638493
NCT02638493N/ACompleted
CompareCT.gov

IGHID 11526 - The Compartmental Biology of HIV in the Male Genital Tract

University of North Carolina, Chapel Hill·observational·Posted Dec 23, 2015·Updated Jul 24, 2017

In Brief

An observational study for Human Immunodeficiency Virus and Virus Shedding. Completed, enrolled 26 participants across 1 site.

Detailed Summary

Male participants taking tenofovir-emtricitabine (TDF/FTC) will provide semen and blood samples which will be analyzed to better understand the pharmacology of antiretroviral therapy in the male genital tract.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHuman Immunodeficiency Virus, Virus Shedding
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 23, 2015
Enrollment StartDec 1, 2015
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.5 years ago